Pages that link to "Q45150040"
Jump to navigation
Jump to search
The following pages link to Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL). (Q45150040):
Displayed 34 items.
- Multiple roles of toll-like receptor 4 in colorectal cancer (Q27008380) (← links)
- Evaluation of the role of TAX, HBZ, and HTLV-1 proviral load on the survival of ATLL patients. (Q33889946) (← links)
- HTLV-1 positive and negative T cells cloned from infected individuals display telomerase and telomere genes deregulation that predominate in activated but untransformed CD4+ T cells (Q33946851) (← links)
- KSHV vCyclin counters the senescence/G1 arrest response triggered by NF-κB hyperactivation (Q33955300) (← links)
- Seizing of T cells by human T-cell leukemia/lymphoma virus type 1. (Q34273466) (← links)
- Molecular mechanisms of cellular transformation by HTLV-1 Tax. (Q34450092) (← links)
- The evolution of thymic lymphomas in p53 knockout mice (Q34590256) (← links)
- Cellular transformation by the HTLV-I Tax protein, a jack-of-all-trades (Q35196610) (← links)
- T-cell control by human T-cell leukemia/lymphoma virus type 1. (Q35611762) (← links)
- IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma (Q35750929) (← links)
- Treatment of T-cell non-Hodgkin's lymphoma. (Q35826477) (← links)
- Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia (Q35847654) (← links)
- Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. (Q35848284) (← links)
- Adult T cell leukemia lymphoma (Q35880693) (← links)
- Negative regulation of the SH2-homology containing protein-tyrosine phosphatase-1 (SHP-1) P2 promoter by the HTLV-1 Tax oncoprotein (Q35990647) (← links)
- Impact of transforming viruses on cellular mutagenesis, genome stability, and cellular transformation (Q36006754) (← links)
- Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response (Q36254875) (← links)
- Inactivation of tumor suppressor genes and the progression of adult T-cell leukemia-lymphoma (Q36291265) (← links)
- Cotranscriptional Chromatin Remodeling by Small RNA Species: An HTLV-1 Perspective (Q36417492) (← links)
- Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis (Q36494000) (← links)
- Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia (Q36682843) (← links)
- Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation (Q36948607) (← links)
- Cluster Analysis of Tumor Suppressor Genes in Canine Leukocytes Identifies Activation State (Q37114738) (← links)
- Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability (Q37169145) (← links)
- Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma (ATL). (Q37435369) (← links)
- Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells. (Q37731757) (← links)
- The targeting of immunosuppressive mechanisms in hematological malignancies (Q38201231) (← links)
- Smoking is a risk factor for development of adult T-cell leukemia/lymphoma in Japanese human T-cell leukemia virus type-1 carriers (Q39604313) (← links)
- cMyc-p53 feedback mechanism regulates the dynamics of T lymphocytes in the immune response (Q41878064) (← links)
- Hmga1 is differentially expressed and mediates silencing of the CD4/CD8 loci in T cell lineages and leukemic cells. (Q44035793) (← links)
- Viral Oncology: Molecular Biology and Pathogenesis (Q47571734) (← links)
- Mutations in the retinoblastoma-related gene RB2/p130 in adult T-cell leukaemia/lymphoma (Q47883995) (← links)
- Interruption of p16 gene expression in adult T-cell leukaemia/lymphoma: clinical correlation. (Q54765386) (← links)
- Harnessing PD-L1-specific cytotoxic T cells for anti-leukemia immunotherapy to defeat mechanisms of immune escape mediated by the PD-1 pathway (Q61698788) (← links)